CCL3 and rheumatoid arthritis: Several recent studies demonstrated the role of chemokines, including RANTES/CCL5, MIP-α/CCL3, and eotaxin-3/CCL26 in the progression of RA (Murayama et al. 2023; Yang et al. 2023).